JP5495709B2 - Skin cleanser composition - Google Patents
Skin cleanser composition Download PDFInfo
- Publication number
- JP5495709B2 JP5495709B2 JP2009243457A JP2009243457A JP5495709B2 JP 5495709 B2 JP5495709 B2 JP 5495709B2 JP 2009243457 A JP2009243457 A JP 2009243457A JP 2009243457 A JP2009243457 A JP 2009243457A JP 5495709 B2 JP5495709 B2 JP 5495709B2
- Authority
- JP
- Japan
- Prior art keywords
- component
- mass
- composition
- fatty acid
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims description 60
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 39
- 239000000194 fatty acid Substances 0.000 claims description 39
- 229930195729 fatty acid Natural products 0.000 claims description 39
- 150000004665 fatty acids Chemical class 0.000 claims description 35
- 229920001525 carrageenan Polymers 0.000 claims description 25
- 235000010418 carrageenan Nutrition 0.000 claims description 23
- 239000000679 carrageenan Substances 0.000 claims description 22
- 229940113118 carrageenan Drugs 0.000 claims description 22
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 22
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 claims description 8
- CAYHVMBQBLYQMT-UHFFFAOYSA-N 2-decyltetradecan-1-ol Chemical compound CCCCCCCCCCCCC(CO)CCCCCCCCCC CAYHVMBQBLYQMT-UHFFFAOYSA-N 0.000 claims description 6
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 claims description 6
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 5
- -1 fatty acid salt Chemical class 0.000 description 19
- 238000011156 evaluation Methods 0.000 description 16
- 239000000344 soap Substances 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 239000003599 detergent Substances 0.000 description 15
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 13
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 10
- 238000005187 foaming Methods 0.000 description 10
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 10
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 10
- 238000003860 storage Methods 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 239000005639 Lauric acid Substances 0.000 description 6
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- 235000021314 Palmitic acid Nutrition 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 239000003513 alkali Substances 0.000 description 5
- 229960003237 betaine Drugs 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 238000002425 crystallisation Methods 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- 230000001815 facial effect Effects 0.000 description 5
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 5
- 239000002453 shampoo Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- 239000002738 chelating agent Substances 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 229940100608 glycol distearate Drugs 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 235000021360 Myristic acid Nutrition 0.000 description 3
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920000800 acrylic rubber Polymers 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 238000005243 fluidization Methods 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- ZONJATNKKGGVSU-UHFFFAOYSA-N 14-methylpentadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCC(O)=O ZONJATNKKGGVSU-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- DEMBLPGWNXUBIQ-UHFFFAOYSA-N 2-dodecylhexadecan-1-ol Chemical compound CCCCCCCCCCCCCCC(CO)CCCCCCCCCCCC DEMBLPGWNXUBIQ-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- GBZDALHFANHWOF-UHFFFAOYSA-N 2-methyloctadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(C)C(O)=O GBZDALHFANHWOF-UHFFFAOYSA-N 0.000 description 1
- RTXVDAJGIYOHFY-UHFFFAOYSA-N 2-tetradecyloctadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCC(CO)CCCCCCCCCCCCCC RTXVDAJGIYOHFY-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 101100061515 Caenorhabditis elegans csk-1 gene Proteins 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 150000004650 carbonic acid diesters Chemical class 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000004520 water soluble gel Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Description
本発明は皮膚洗浄剤組成物に関する。 The present invention relates to a skin cleanser composition.
従来より、皮膚洗浄剤には、固形石鹸、ボディーシャンプー、ハンドソープ、洗顔フォームなどがある。これら皮膚洗浄剤の主成分としては、豊かな泡立ちやさっぱりとした洗い上がりと言った、日本人の嗜好に合致した使用性・機能性に加え、安全性、コストなどの面から、脂肪酸石鹸が依然として中心である。 Conventionally, skin cleansing agents include bar soap, body shampoo, hand soap, and facial cleansing foam. The main components of these skin cleansers are fatty acid soaps from the viewpoints of safety, cost, etc., in addition to usability and functionality that match the tastes of Japanese people, such as rich foaming and refreshing washing. Still central.
また、皮膚洗浄剤の剤型も生活スタイルへの対応から、従来の固形タイプから、液状、ジェル状、クリーム状、泡状などの多様な剤型へとシフトしている。しかし、脂肪酸石鹸系洗浄剤をジェル状、クリーム状などの剤型とすると、高温で脂肪酸が融解しやすく、しかも常温への戻り時には結晶化(固化)するため、融解・固化の繰り返しによりバルク硬度が上昇するといった問題がある。したがって、脂肪酸石鹸系洗浄剤をジェル状やクリーム状などの剤型にすると、高温下での安定性を付与しなければならないといった技術的な課題がある。 In addition, the form of skin cleansing agent has been shifted from the conventional solid type to various dosage forms such as liquid, gel, cream and foam because of its lifestyle. However, if the fatty acid soap detergent is in the form of gel or cream, the fatty acid is easily melted at high temperature and crystallizes (solidifies) when it returns to room temperature. Therefore, bulk hardness is achieved by repeated melting and solidification. There is a problem of rising. Therefore, when the fatty acid soap-based detergent is in a gel form or cream form, there is a technical problem that stability at high temperatures must be imparted.
また、脂肪酸石鹸系洗浄剤を液状の剤型とする場合、ハンドリングを高めるために系を増粘する必要がある。しかし、脂肪酸を高配合させることにより増粘すると、低温保管時に脂肪酸の析出が生じやすくなるといった問題がある。 Moreover, when making a fatty-acid soap type | system | group detergent into a liquid dosage form, in order to improve handling, it is necessary to thicken a type | system | group. However, when the viscosity is increased by adding a high amount of fatty acid, there is a problem that precipitation of the fatty acid is likely to occur during low-temperature storage.
このような問題点を解決するために、例えば、高級脂肪酸石鹸とアクリル酸アルキルコポリマーとを含有させることにより、液状洗浄剤のハンドリングを高めた洗浄剤(特許文献1参照)や、高級脂肪酸石鹸と低級アルコールを特定量組み合わせることにより、保存安定性に優れ良好な水溶けや起泡性を有するペースト状の皮膚洗浄剤(特許文献2参照)などが提案されている。 In order to solve such problems, for example, a higher fatty acid soap and an alkyl acrylate copolymer are included to improve the handling of the liquid detergent (see Patent Document 1), and higher fatty acid soap and By combining a specific amount of a lower alcohol, a paste-like skin cleansing agent having excellent storage stability and good water solubility and foaming properties (see Patent Document 2) has been proposed.
しかしながら、アクリル酸アルキルコポリマーを高配合して高粘度を得ようとすると、使用時にポリマー独特の粘着感が生じる上に、起泡力も低下してしまうといった問題がある。また、高級脂肪酸石鹸と低級アルコールを特定量組み合わせる技術は、脂肪酸を高配合しなければならず粘度調整が難しいことに加えて、低級アルコールの揮発による経時的な系の不安定化も起こりえるといった問題がある。 However, when trying to obtain a high viscosity by blending a high amount of an alkyl acrylate copolymer, there is a problem in that a sticky feeling peculiar to the polymer is produced at the time of use, and foaming power is also reduced. In addition, the technology that combines a certain amount of higher fatty acid soap and lower alcohol requires high blending of fatty acids, making it difficult to adjust the viscosity, and may cause the system to become unstable over time due to volatilization of the lower alcohol. There's a problem.
一方、カラギーナンは、従来よりゲル化剤または増粘剤として使用されている。ここで、カラギーナンを洗浄剤に応用した例としては、カラギーナン、炭酸ジエステル、塩化ナトリウムを含有するクレンジング用の皮膚外用剤(特許文献3参照)、カラギーナン、洗浄剤、香料を含有する水溶性ゲル状芳香洗浄ゲル組成物(特許文献4参照)などが提案されている。 On the other hand, carrageenan has been conventionally used as a gelling agent or thickener. Here, as an example of applying carrageenan to a cleaning agent, carrageenan, carbonic acid diester, a cleansing skin external preparation containing sodium chloride (see Patent Document 3), carrageenan, a detergent, and a water-soluble gel containing a fragrance. An aromatic cleaning gel composition (see Patent Document 4) has been proposed.
しかしながら、上記カラギーナンを用いた洗浄剤は、メイクアップ除去用のクレンジング剤の増粘や、トイレに設置して使う所謂芳香剤などであり、カラギーナンが、洗顔フォームに代表される脂肪酸石鹸系洗浄剤を安定化させることについては全く知られていない。 However, the above-mentioned detergent using carrageenan is a thickener of cleansing agent for removing makeup, a so-called fragrance used in a toilet, etc., and carrageenan is a fatty acid soap-based detergent represented by facial cleansing foam. There is no known at all about stabilizing.
本発明は、上記従来技術に鑑みて為されたものであって、脂肪酸石鹸系洗浄剤で起こる、高温保管時での融解および常温戻り時での結晶化の繰り返しによるバルク硬度の上昇を防ぎ、種々の温度条件下においても保管安定性に優れ、しかも起泡性や水馴染みなどの使用感にも優れる皮膚洗浄剤組成物を提供することを課題とする。 The present invention has been made in view of the above prior art, and prevents an increase in bulk hardness caused by repeated melting and crystallization at the time of returning to room temperature, which occurs in a fatty acid soap-based detergent, It is an object of the present invention to provide a skin cleanser composition that is excellent in storage stability even under various temperature conditions, and also excellent in feeling of use such as foamability and familiarity with water.
すなわち、本発明は、
〔1〕(A)直鎖高級脂肪酸、(B)カッパ型、イオタ型、およびラムダ型の群から選ばれる少なくとも1種であるカラギーナン並びに(C)分岐鎖高級脂肪酸及び/または分岐鎖高級アルコールを含有し、(A)成分の含有量は、1〜60質量%であり、(B)成分の含有量は、0.05〜10質量%であり、(C)成分の含有量は、0.05〜5質量%である皮膚洗浄剤組成物、
〔2〕(C)成分の分岐鎖高級脂肪酸が、イソステアリン酸であることを特徴とする、前記〔1〕記載の皮膚洗浄剤組成物、
〔3〕(C)成分の分岐鎖高級アルコールが、イソステアリルアルコール、オクチルドデカノールおよびデシルテトラデカノールの群から選ばれる少なくとも1種であることを特徴とする、前記〔1〕又は〔2〕記載の皮膚洗浄剤組成物、
〔4〕(B)成分と(C)成分との質量含有比〔(B)/(C)〕は、3/10〜5/1であることを特徴とする前記〔1〕〜〔3〕の何れか一つに記載の皮膚洗浄剤組成物、並びに
〔5〕半固形状であることを特徴とする、前記〔1〕〜〔4〕の何れか一つに記載の皮膚洗浄剤組成物
に関するものである。
That is, the present invention
[1] (A) a linear higher fatty acid, (B) at least one carrageenan selected from the group of kappa type, iota type, and lambda type, and (C) a branched higher fatty acid and / or a branched higher alcohol. And the content of the component (A) is 1 to 60% by mass, the content of the component (B) is 0.05 to 10% by mass, and the content of the component (C) is 0.8. 05-5% by mass Ru skin cleansing composition,
[2] The skin cleansing composition according to [1] above, wherein the branched chain higher fatty acid of component (C) is isostearic acid,
[3] (C) component of the branched-chain higher alcohols, isostearyl alcohol, characterized in that it is a one to as least selected from the group consisting of octyl dodecanol and decyl tetradecanol, wherein [1] or [ 2] The skin cleansing composition according to the above ,
[4] The mass content ratio [(B) / (C)] of the component (B) and the component (C) is 3/10 to 5/1, [1] to [3] A skin cleanser composition according to any one of
[5] The skin cleansing composition according to any one of [1] to [ 4 ], which is semi-solid.
本発明の皮膚洗浄剤組成物は、脂肪酸石鹸系洗浄剤で起こる、高温保管時での融解および常温戻り時での結晶化の繰り返しによるバルク硬度の上昇を防ぎ、種々の温度条件下においても保管安定性に優れ、しかも起泡性や水馴染み等の使用感にも優れるという効果を奏する。 The skin cleanser composition of the present invention prevents the increase in bulk hardness due to repeated melting at high temperature storage and crystallization at room temperature return, which occurs with fatty acid soap-based cleansing agents, and can be stored under various temperature conditions. Excellent stability and excellent usability such as foaming and water familiarity.
本発明の皮膚洗浄剤組成物は、(A)直鎖高級脂肪酸、(B)カラギーナン並びに(C)分岐鎖高級脂肪酸及び/または分岐鎖高級アルコールを含有する。 The skin cleansing composition of the present invention contains (A) a linear higher fatty acid, (B) carrageenan, and (C) a branched higher fatty acid and / or a branched higher alcohol.
(A)成分の直鎖高級脂肪酸としては、例えば、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、ベヘニン酸などの炭素数12〜22の高級脂肪酸;オリーブ油、ヤシ油、パーム油、綿実油などの植物性油脂;魚油、牛脂などの動物性油脂などを例示することができる。これら成分は、1種を単独で用いてもよく、又は2種以上を適宜併用して用いてもよい。好適な(A)成分としては、洗浄力の観点から、炭素数12〜22の高級脂肪酸を用いるのが好ましく、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸がより好ましく用いられる。 Examples of the linear higher fatty acid (A) include higher fatty acids having 12 to 22 carbon atoms such as lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, and behenic acid; olive oil, coconut oil, palm oil, Examples include vegetable oils such as cottonseed oil; animal oils such as fish oil and beef tallow. These components may be used individually by 1 type, or may be used in combination of 2 or more types as appropriate. As a suitable component (A), from the viewpoint of detergency, it is preferable to use a higher fatty acid having 12 to 22 carbon atoms, and lauric acid, myristic acid, palmitic acid, and stearic acid are more preferably used.
(A)成分の直鎖高級脂肪酸は、通常、アルカリ剤でケン化、又は中和した直鎖高級脂肪酸塩として用いられる。用いられるアルカリ剤としては、水酸化ナトリウム、水酸化カリウム、炭酸ナトリウム、炭酸カリウムなどの無機アルカリ;モノエタノールアミン、ジエタノールアミン、トリエタノールアミン、トリメチルアミン、トリエチルアミンなどの有機アルカリなどが挙げられる。使用するアルカリ剤としては、材料入手の容易性および取り扱いの簡便性の観点から、水酸化ナトリウム、水酸化カリウム、トリエタノールアミンを用いることが好ましい。 The straight chain higher fatty acid (A) is usually used as a straight chain higher fatty acid salt saponified or neutralized with an alkali agent. Examples of the alkali agent used include inorganic alkalis such as sodium hydroxide, potassium hydroxide, sodium carbonate and potassium carbonate; organic alkalis such as monoethanolamine, diethanolamine, triethanolamine, trimethylamine and triethylamine. As the alkali agent to be used, it is preferable to use sodium hydroxide, potassium hydroxide, or triethanolamine from the viewpoint of easy availability of materials and easy handling.
本発明の皮膚洗浄剤に直鎖高級脂肪酸塩を含有させるには、直鎖高級脂肪酸とアルカリ剤を予め直鎖高級脂肪酸塩として調製後に配合してもよく、また、直鎖高級脂肪酸とアルカリ剤とを配合して組成物中で直鎖高級脂肪酸塩としてもよい。 In order to contain the linear higher fatty acid salt in the skin cleansing agent of the present invention, the linear higher fatty acid and the alkali agent may be blended after preparing as a linear higher fatty acid salt in advance, or the linear higher fatty acid and the alkali agent. And may be used as a straight chain higher fatty acid salt in the composition.
上記(A)成分の含有量は、本発明の効果を発揮すれば特に限定されるものではないが、起泡性や洗浄力を高める観点から、1質量%以上が好ましく、5質量%以上がより好ましい。また、皮膚刺激や水馴染みの観点から、60質量%以下が好ましく、50質量%以下がより好ましい。これらから、(A)成分の含有量は、皮膚洗浄剤組成物中、好ましくは1〜60質量%、より好ましくは5〜50質量%である。 Although content of the said (A) component is not specifically limited if the effect of this invention is exhibited, From a viewpoint of improving foamability and detergency, 1 mass% or more is preferable, and 5 mass% or more is preferable. More preferred. Further, from the viewpoint of skin irritation and familiarity with water, 60% by mass or less is preferable, and 50% by mass or less is more preferable. Accordingly, the content of the component (A) is preferably 1 to 60% by mass, more preferably 5 to 50% by mass in the skin cleanser composition.
(B)成分のカラギーナンには、ミュー型、カッパ型、ニュー型、イオタ型、ラムダ型、クシー型、シータ型などの異性体がある。本発明においては、少量で直鎖高級脂肪酸およびその塩の結晶分散効果および高温下での流動性抑制効果をより発揮できる観点から、カッパ型、イオタ型、ラムダ型のカラギーナンを用いることが好ましい。これら成分は、1種を単独で用いてもよく、又は2種以上を併用してもよい。 The component (B) carrageenan includes isomers such as mu, kappa, new, iota, lambda, xy, and theta. In the present invention, it is preferable to use kappa-type, iota-type, and lambda-type carrageenans from the viewpoint that the effect of crystal dispersion of linear higher fatty acids and salts thereof and the effect of suppressing fluidity at high temperatures can be further exhibited in a small amount. These components may be used individually by 1 type, or may use 2 or more types together.
なお、(B)成分は、市販品を用いることもできる。カッパ型カラギーナンとしては、例えば、カラギーナンCSK−1(商品名:三栄源エスエフアイ社製)、カラギーナンCS−1(商品名:伊那食品工業社製)、ゲニューゲルWG、ゲニューゲルWR(商品名:いずれもコペンハーゲンペクチンファクトリー社製)などを例示することができる。イオタ型カラギーナンとしては、例えば、カラギーナンCSI−1(商品名:三栄源エスエフアイ社製)、カラギーナンCS−2(商品名:伊那食品工業社製)、ゲニュービスコJ−J、ゲニューゲルCJ、ゲニュービスコPJ−JPE(商品名:いずれもコペンハーゲンペクチンファクトリー社製)などを例示することができる。ラムダ型カラギーナンとしては、例えば、カラギーナンCSF−1(商品名:三栄源エスエフアイ社製)、カラギーナンCS−3(商品名:伊那食品工業社製)などを例示することができる。かかる成分は、性能の点に加えて入手が容易な点で、好ましい。 In addition, a commercial item can also be used for (B) component. Examples of the kappa type carrageenan include carrageenan CSK-1 (trade name: manufactured by Saneigen SFI Co., Ltd.), carrageenan CS-1 (trade name: manufactured by Ina Food Industry Co., Ltd.), Genugel WG, Genugel WR (Brand name: All Copenhagen Pectin Factory) and the like. Examples of the iota-type carrageenan include carrageenan CSI-1 (trade name: manufactured by Saneigen SFFI Co., Ltd.), carrageenan CS-2 (trade name: manufactured by Ina Food Industry Co., Ltd.), Genuine Bisco JJ, Genuine Gel CJ, Genuine Bisco PJ- Examples include JPE (trade name: all manufactured by Copenhagen Pectin Factory). Examples of the lambda type carrageenan include carrageenan CSF-1 (trade name: manufactured by Saneigen SFI Corporation), carrageenan CS-3 (trade name: manufactured by Ina Food Industry Co., Ltd.), and the like. Such a component is preferable in terms of easy availability in addition to performance.
上記(B)成分の含有量は、本発明の効果を発揮すれば特に限定されるものではないが、高温下での流動性抑制効果を発揮させる観点から、0.05質量%以上が好ましく、0.1質量%以上がより好ましい。また、使用時のべたつきやぬるつきを軽減する観点から、10質量%以下が好ましく、5質量%以下がより好ましい。これらから、(B)成分の含有量は、皮膚洗浄剤組成物中、好ましくは0.05〜10質量%、より好ましくは0.1〜5質量%である。 The content of the component (B) is not particularly limited as long as the effect of the present invention is exhibited, but from the viewpoint of exerting the fluidity suppressing effect at high temperatures, 0.05% by mass or more is preferable, 0.1 mass% or more is more preferable. Moreover, 10 mass% or less is preferable from a viewpoint of reducing the stickiness and sliminess at the time of use, and 5 mass% or less is more preferable. From these, the content of the component (B) is preferably 0.05 to 10% by mass, more preferably 0.1 to 5% by mass in the skin cleanser composition.
(C)成分の分岐鎖高級脂肪酸としては、例えば、イソステアリン酸、イソパルミチン酸、α‐メチルオクタデカン酸、長鎖分岐脂肪酸(C12‐31)、長鎖分岐脂肪酸(C14‐28)等が挙げられる。これら(C)成分は、天然物由来品でも合成品であってもよい。 Examples of the branched chain higher fatty acid of component (C) include isostearic acid, isopalmitic acid, α-methyloctadecanoic acid, long chain branched fatty acid (C12-31), and long chain branched fatty acid (C14-28). . These components (C) may be natural products or synthetic products.
また、(C)成分の分岐鎖高級アルコールとしては、例えば、イソステアリルアルコール、ヘキシルデカノール、オクチルドデカノール、コレステロール、フィトステロール、テトラデシルオクタデカノール、デシルテトラデカノール、ドデシルヘキサデカノールなどが挙げられる。これら(C)成分は、天然物由来品でも合成品であってもよい。尚、前記した(C)成分は、1種を単独で用いてもよく、又は2種以上を併用してもよい。 Examples of the branched chain higher alcohol (C) include isostearyl alcohol, hexyldecanol, octyldodecanol, cholesterol, phytosterol, tetradecyloctadecanol, decyltetradecanol, and dodecylhexadecanol. These components (C) may be natural products or synthetic products. In addition, an above described component (C) may be used individually by 1 type, or may use 2 or more types together.
好適な(C)成分としては、高温下での流動性防止の観点および結晶化抑制の観点から、分岐鎖高級脂肪酸としては、イソステアリン酸を用いることが好ましく、また、分岐型高級アルコールとしては、イソステアリルアルコール、デシルテトラデカノール、及びオクチルドデカノールを用いることが好ましい。 As a suitable component (C), from the viewpoint of preventing fluidity at high temperatures and from the viewpoint of suppressing crystallization, it is preferable to use isostearic acid as the branched higher fatty acid, and as the branched higher alcohol, It is preferable to use isostearyl alcohol, decyltetradecanol, and octyldodecanol.
上記(C)成分の含有量は、本発明の効果を発揮すれば特に限定されるものではないが、結晶化抑制の観点から、好ましくは0.05質量%以上、より好ましくは0.1質量%以上である。また、高温下での流動性防止の観点から、皮膚洗浄剤組成物中、好ましくは5質量%以下、より好ましくは3質量%以下である。これらから、(C)成分の含有量は、皮膚洗浄剤組成物中、好ましくは0.05〜5質量%、より好ましくは0.1〜3質量%である。 The content of the component (C) is not particularly limited as long as the effects of the present invention are exhibited, but from the viewpoint of suppressing crystallization, it is preferably 0.05% by mass or more, more preferably 0.1% by mass. % Or more. Moreover, from a viewpoint of fluidity | liquidity prevention at high temperature, Preferably it is 5 mass% or less in a skin cleaning composition, More preferably, it is 3 mass% or less. Accordingly, the content of component (C) is preferably 0.05 to 5% by mass, more preferably 0.1 to 3% by mass in the skin cleanser composition.
(B)成分と(C)成分との質量含有比〔(B)/(C)〕は、本発明の効果を発揮すれば特に限定されるものではないが、優れた経時的な硬度安定性を発揮させる観点から、皮膚洗浄剤組成物中、好ましくは〔(B)/(C)〕=1/10〜10/1、より好ましくは〔(B)/(C)〕=2/10〜7/1、さらに好ましくは〔(B)/(C)〕=3/10〜5/1である。 The mass content ratio [(B) / (C)] of the component (B) and the component (C) is not particularly limited as long as the effect of the present invention is exhibited, but excellent hardness stability over time. In the skin cleanser composition, preferably [(B) / (C)] = 1/10 to 10/1, more preferably [(B) / (C)] = 2/10. 7/1, more preferably [(B) / (C)] = 3/10 to 5/1.
また、(B)成分と(C)成分との質量の和としては、本発明の効果を発揮すれば特に限定されるものではないが、高温下での流動性抑制を発揮させる観点から、皮膚洗浄剤組成物中、好ましくは0.1〜10質量%、より好ましくは0.2〜8質量%、さらに好ましくは0.5〜5質量%である。 Further, the sum of the masses of the component (B) and the component (C) is not particularly limited as long as the effect of the present invention is exhibited, but from the viewpoint of exhibiting fluidity suppression at high temperatures, the skin In a cleaning composition, Preferably it is 0.1-10 mass%, More preferably, it is 0.2-8 mass%, More preferably, it is 0.5-5 mass%.
本発明の皮膚洗浄剤組成物には、洗浄性を高める観点から、高級脂肪酸石鹸以外の界面活性剤を含有させることができる。用いられる界面活性剤としては、例えば、ラウリン酸アシルメチルタウリン塩、ポリオキシエチレン酢酸エーテル塩、アルキルアシルグルタミン酸塩、アルキルアシルグリシン塩、アルキルリン酸塩、ポリオキシエチレンアルキルリン酸塩等の陰イオン性界面活性剤;アルキルアミドプロピルベタイン、アルキルアミノ酢酸ベタイン、アルキルイミダゾリウムベタイン、アルキルヒドロキシエチルベタイン等の両性界面活性剤;モノステアリン酸ポリエチレングリコール、ジステアリン酸ポリエチレングリコール、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビタンエステル、モノステアリン酸グリセリン、ポリオキシエチレンコレステロールエーテル、ポリオキシエチレンフィトステロールエーテルなどの非イオン性界面活性剤等が挙げられる。これら成分は、1種を単独で用いてもよく、又は2種以上を併用してもよい。高級脂肪酸石鹸以外の界面活性剤の含有量は特に限定されないが、例えば、皮膚洗浄剤組成物中、好ましくは0.1〜30質量%、より好ましくは1.0〜20質量%である。 The skin cleansing composition of the present invention can contain a surfactant other than the higher fatty acid soap from the viewpoint of improving the cleanability. Examples of the surfactant used include anions such as lauric acid acylmethyl taurate, polyoxyethylene acetate ether salt, alkyl acyl glutamate, alkyl acyl glycine salt, alkyl phosphate, polyoxyethylene alkyl phosphate, etc. Amphoteric surfactants such as alkylamidopropyl betaine, alkylaminoacetic acid betaine, alkylimidazolium betaine, alkylhydroxyethyl betaine; polyethylene glycol monostearate, polyethylene glycol distearate, polyoxyethylene hydrogenated castor oil, poly Nonionic surface activity such as oxyethylene sorbitan ester, glyceryl monostearate, polyoxyethylene cholesterol ether, polyoxyethylene phytosterol ether Agent, and the like. These components may be used individually by 1 type, or may use 2 or more types together. Although content of surfactant other than higher fatty acid soap is not specifically limited, For example, in a skin cleansing composition, Preferably it is 0.1-30 mass%, More preferably, it is 1.0-20 mass%.
また、本発明の皮膚洗浄剤組成物には、安定性を高める観点から、多価アルコールを含有させることができる。用いられる多価アルコールとしては、化粧料原料として使用できるものであれば特に限定されないが、例えば、グリセリン、濃グリセリン、ジグリセリン、ポリグリセリン、エチレングリコール、ポリエチレングリコール、プロピレングリコール、ジプロピレングリコール、1,3−ブチレングリコール、グルコース、マルトース、マルチトース、スクロース、マンニトール、ソルビトール、1,2−ペンタンジオール、1,2−ヘキサンジオール、1,2−オクタンジオール等が好ましい例として挙げられる。これら成分は、1種を単独で用いてもよく、又は2種以上を併用してもよい。多価アルコールの含有量は特に限定されないが、例えば、皮膚洗浄剤組成物中、好ましくは0.1〜50質量%、より好ましくは1〜40質量%である。 Moreover, the skin cleansing composition of the present invention can contain a polyhydric alcohol from the viewpoint of enhancing stability. The polyhydric alcohol used is not particularly limited as long as it can be used as a cosmetic raw material. For example, glycerin, concentrated glycerin, diglycerin, polyglycerin, ethylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol, 1 Preferred examples include 1,3-butylene glycol, glucose, maltose, maltose, sucrose, mannitol, sorbitol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol and the like. These components may be used individually by 1 type, or may use 2 or more types together. Although content of a polyhydric alcohol is not specifically limited, For example, in skin cleaning composition, Preferably it is 0.1-50 mass%, More preferably, it is 1-40 mass%.
本発明に係る皮膚洗浄剤組成物には、本発明の効果を損なわない範囲であれば、上記に記した成分の他、l−メントール、カンファ、l−メンチルグリセリルエーテル等の清涼剤;酸化防止剤、キレート剤、シリコーン類、ビタミン類、動植物エキス、抗炎症剤、粉体類、パール化剤、着色剤、各種香料、防腐剤、殺菌剤、pH調整剤等を目的に応じて適宜配合してもよい。 In the skin cleanser composition according to the present invention, as long as the effects of the present invention are not impaired, a refreshing agent such as l-menthol, camphor, and l-menthyl glyceryl ether in addition to the components described above; Additives, chelating agents, silicones, vitamins, animal and plant extracts, anti-inflammatory agents, powders, pearling agents, coloring agents, various fragrances, preservatives, bactericides, pH adjusters, etc. May be.
本発明の皮膚洗浄剤組成物の用途は特に制限されないが、動物の皮膚用、特にヒトの皮膚用に適している。具体的には、頭皮用のシャンプー、皮膚用のボディーシャンプー、ハンドソープ、顔用の洗顔料、足用ソープ等、ヒトのいずれの部位にも使用することができる。本発明の皮膚洗浄剤組成物は、使用時の水馴染みに優れ、洗い流し時のぬるつきが抑えられるという優れた利点を有することから、ボディーシャンプー、洗顔料といった顔用・ボディー用皮膚洗浄剤として使用されるのがより好ましい。 The use of the skin cleansing composition of the present invention is not particularly limited, but is suitable for animal skin, particularly human skin. Specifically, it can be used for any part of human, such as scalp shampoo, skin body shampoo, hand soap, facial cleanser, foot soap. Since the skin cleansing composition of the present invention has excellent advantages of being familiar with water at the time of use and being able to suppress the stickiness at the time of washing, it can be used as a skin cleansing agent for face and body such as body shampoo and facial cleanser. More preferably it is used.
また、本発明の皮膚洗浄剤組成物の剤型は、液状、乳液状、ジェル状、クリーム状、ペースト状等の種々の剤型として用いることができる。なかでも、経時的な保管安定性に優れる観点から、クリーム状、ペースト状等の半固形状とすることが好ましい。尚、本発明における「半固形」とは、室温で流動性のない状態をいう。 Moreover, the dosage form of the skin cleansing composition of the present invention can be used as various dosage forms such as liquid, emulsion, gel, cream and paste. Of these, from the viewpoint of excellent storage stability over time, a semi-solid form such as cream or paste is preferable. In the present invention, “semi-solid” means a state having no fluidity at room temperature.
(組成物の調製)
表1及び表2に記した組成に従い、実施例1〜5及び比較例1〜4の各皮膚洗浄剤組成物を常法に従って調製した。得られた各組成物をそれぞれ透明チューブ容器に充填し、洗顔料の形態で、下記評価試験に供した。結果をそれぞれ表1及び2に併記する。
なお、配合量は、特記しない限り「質量%」を表す。また、表中の「適量」とは、10%水酸化カリウム水溶液を用いて、組成物のpHを9.5に調整する量を指す。
(Preparation of composition)
According to the composition described in Table 1 and Table 2, each skin cleaning composition of Examples 1-5 and Comparative Examples 1-4 was prepared in accordance with the conventional method. Each of the obtained compositions was filled in a transparent tube container and subjected to the following evaluation test in the form of a face wash. The results are shown in Tables 1 and 2, respectively.
The blending amount represents “% by mass” unless otherwise specified. Further, “appropriate amount” in the table refers to an amount for adjusting the pH of the composition to 9.5 using a 10% aqueous potassium hydroxide solution.
(試験例1:水馴染みの評価)
チューブ容器から、各組成物を手の平に1cm取り出し、水を5g加えて両手で擦り合わせて泡立てた時の水馴染みを、以下の評価基準に従って評価した。
(Test Example 1: Evaluation of familiarity with water)
From the tube container, 1 cm of each composition was taken out in the palm of the hand, 5 g of water was added, and the water familiarity when foamed by rubbing with both hands was evaluated according to the following evaluation criteria.
<評価基準>
◎:組成物と水が、手を2往復以内に混ざり合う。
○:組成物と水が、手を2往復を超え5往復以内に混ざり合う。
△:組成物と水が、手を5往復を超え10往復以内に混ざり合う。
×:組成物と水が、手を10往復以内に擦り合わせても混ざり合わない。
<Evaluation criteria>
(Double-circle): A composition and water mix a hand within two reciprocations.
○: The composition and water are mixed within 5 round trips, exceeding 2 round trips.
(Triangle | delta): A composition and water mix a hand within 5 round trips exceeding 5 round trips.
X: The composition and water do not mix even if the hands are rubbed within 10 reciprocations.
(試験例2:起泡力の評価)
チューブ容器から、各組成物を手の平に1cm取り出し、水を5g加えて両手で擦り合わせて泡立てた時の起泡力を、以下の評価基準に従って評価した。本評価は、官能評価パネル20名により実施した。
(Test Example 2: Evaluation of foaming power)
From the tube container, 1 cm of each composition was taken out into the palm of the hand, 5 g of water was added, and the foaming force when foamed by rubbing with both hands was evaluated according to the following evaluation criteria. This evaluation was performed by 20 sensory evaluation panels.
<評価基準>
◎:20名中16名以上が起泡力に優れると回答
○:20名中11〜15名が起泡力に優れると回答
△:20名中6〜10名が起泡力に優れると回答
×:20名中5名以下が起泡力に優れると回答
<Evaluation criteria>
◎: Reply if 16 or more out of 20 are excellent in foaming ability ○: Reply if 11-15 out of 20 are excellent in foaming ability △: Reply that 6-10 out of 20 persons are excellent in foaming ability ×: 5 or less out of 20 responded that they have excellent foaming power
(試験例3:高温安定性の評価)
各組成物が充填されたチューブ容器を、40℃の恒温槽にそれぞれ1ヶ月間保管した。恒温槽からの取り出し直後、並びに25℃にて6時間放置後の各組成物の外観を、恒温槽に保管前の組成物と目視で比較観察し、下記評価基準に従い評価した。また、25℃にて6時間放置後の各組成物をチューブから吐出し、その吐出状態を下記評価基準に従い評価した。
(Test Example 3: Evaluation of high-temperature stability)
Each tube container filled with each composition was stored in a constant temperature bath at 40 ° C. for 1 month. Immediately after taking out from the thermostat and after leaving for 6 hours at 25 ° C., the appearance of each composition was visually compared with the composition before storage in the thermostat and evaluated according to the following evaluation criteria. Moreover, each composition after leaving to stand at 25 degreeC for 6 hours was discharged from the tube, and the discharge state was evaluated in accordance with the following evaluation criteria.
<外観の評価基準>
◎:組成物の外観に変化が認められない
○:組成物の外観に僅かに軟化が認められる
△:組成物の外観に分離,析出,流動化の少なくともいずれかの変化が認められる
×:組成物の外観に明らかな分離,析出,流動化の少なくともいずれかの変化が認められる
<Evaluation criteria for appearance>
A: No change is observed in the appearance of the composition B: Slight softening is observed in the appearance of the composition B: At least any change of separation, precipitation, fluidization is observed in the appearance of the composition X: Composition Obvious changes in appearance, separation, precipitation, fluidization are observed
<吐出状態の評価基準>
◎:容器充填時と同様の吐出性である
○:容器充填時と比べ、やや硬い吐出性である
△:容器充填時と比べ、硬い吐出性である
×:組成物の吐出が困難、或いは垂れ落ちによる吐出異常がある
<Evaluation criteria for discharge state>
◎: Discharge property similar to that when filling the container ○: Discharge property that is slightly harder than when filling the container △: Hard discharge property compared with when filling the container ×: Difficult to discharge composition or sagging Discharge abnormality due to drop
(試験例4:変動温度安定性の評価)
各組成物が充填されたチューブ容器を、5℃〜50℃〜5℃の温度範囲を24時間のサイクル温度で変動する恒温槽にそれぞれ1ヶ月間保管した。保管後、恒温槽から取り出して25℃で6時間放置した。その後、組成物の外観の状態、およびチューブから組成物の吐出状態を、試験例3の評価基準を用いて同様に評価した。
(Test Example 4: Evaluation of variable temperature stability)
The tube containers filled with the respective compositions were stored for 1 month in a thermostatic chamber whose temperature range was 5 ° C. to 50 ° C. to 5 ° C. with a cycle temperature of 24 hours. After storage, it was taken out from the thermostat and left at 25 ° C. for 6 hours. Thereafter, the appearance state of the composition and the discharge state of the composition from the tube were similarly evaluated using the evaluation criteria of Test Example 3.
表1及び表2の結果から、各実施例の皮膚洗浄剤組成物は、各比較例のものと対比して、高温保管時での融解および常温戻り時での結晶化の繰り返しによるバルク硬度の上昇をふせぎ、種々の温度条件下においても保管安定性に優れ、しかも使用感に優れるという効果を奏することが分かる。 From the results of Tables 1 and 2, the skin cleanser compositions of each example had a bulk hardness by repeating melting and crystallization at the time of storage at high temperature and reversion to room temperature as compared with those of each comparative example. It can be seen that the increase is suppressed, and the storage stability is excellent even under various temperature conditions, and the usability is excellent.
以下に、本発明に係る皮膚洗浄剤組成物の処方例を以下に示す。
(処方例1:洗顔フォーム)
ラウリン酸 5.0
ミリスチン酸 10.0
パルミチン酸 5.0
ステアリン酸 11.0
カラギーナン(イオタ型) 1.0
オクチルドデカノール 0.5
グリセリン 15.0
1,3−ブチレングリコール 5.0
ポリエチレングリコール1500 5.0
水酸化カリウム 適 量
ラウロイルメチルタウリンナトリウム 2.0
ジステアリン酸ポリエチレングリコール 2.0
ポリオキシエチレンフィトステロールエーテル 1.0
金属キレート剤 適 量
防腐剤 適 量
精製水 残 部
合計 100.0
Below, the formulation example of the skin cleanser composition which concerns on this invention is shown below.
(Prescription Example 1: Facial cleansing foam)
Lauric acid 5.0
Myristic acid 10.0
Palmitic acid 5.0
Stearic acid 11.0
Carrageenan (Iota type) 1.0
Octyldodecanol 0.5
Glycerin 15.0
1,3-butylene glycol 5.0
Polyethylene glycol 1500 5.0
Potassium hydroxide appropriate amount Lauroyl methyl taurine sodium 2.0
Polyethylene glycol distearate 2.0
Polyoxyethylene phytosterol ether 1.0
Metal chelating agent appropriate amount Preservative preserving amount
Purified water balance <br/> Total 100.0
(処方例2:洗顔フォーム)
ラウリン酸 5.0
ミリスチン酸 10.0
パルミチン酸 5.0
ステアリン酸 11.0
カラギーナン(カッパ型) 1.0
デシルテトラデカノール 0.5
オクチルドデカノール 0.5
グリセリン 15.0
ソルビトール 5.0
ポリエチレングリコール1500 5.0
水酸化カリウム 適 量
ラウロイルメチルタウリンナトリウム 2.0
ジステアリン酸ポリエチレングリコール 2.0
N−ステアロイル―L−グルタミン酸ナトリウム 1.0
金属キレート剤 適 量
防腐剤 適 量
精製水 残 部
合計 100.0
(Prescription Example 2: Face-wash form)
Lauric acid 5.0
Myristic acid 10.0
Palmitic acid 5.0
Stearic acid 11.0
Carrageenan (Kappa type) 1.0
Decyltetradecanol 0.5
Octyldodecanol 0.5
Glycerin 15.0
Sorbitol 5.0
Polyethylene glycol 1500 5.0
Potassium hydroxide appropriate amount Lauroyl methyl taurine sodium 2.0
Polyethylene glycol distearate 2.0
N-stearoyl-sodium L-glutamate 1.0
Metal chelating agent appropriate amount Preservative preserving amount
Purified water balance <br/> Total 100.0
(処方例3:ボディシャンプー)
ラウリン酸 5.0
ミリスチン酸 2.5
パルミチン酸 2.5
カラギーナン(ラムダ型) 0.2
デシルテトラデカノール 0.5
塩化ナトリウム 0.5
ジプロピレングリコール 15.0
ソルビトール 5.0
ポリエチレングリコール1500 5.0
トリエタノールアミン 適 量
ラウリン酸アミドプロピルベタイン液(30%水溶液) 10.0
ジステアリン酸ポリエチレングリコール 2.0
N−ステアロイル―L−グルタミン酸ナトリウム 1.0
金属キレート剤 適 量
防腐剤 適 量
精製水 残 部
合計 100.0
(Prescription Example 3: Body Shampoo)
Lauric acid 5.0
Myristic acid 2.5
Palmitic acid 2.5
Carrageenan (lambda type) 0.2
Decyltetradecanol 0.5
Sodium chloride 0.5
Dipropylene glycol 15.0
Sorbitol 5.0
Polyethylene glycol 1500 5.0
Triethanolamine Appropriate amount Amidopropyl betaine laurate solution (30% aqueous solution) 10.0
Polyethylene glycol distearate 2.0
N-stearoyl-sodium L-glutamate 1.0
Metal chelating agent appropriate amount Preservative preserving amount
Purified water balance <br/> Total 100.0
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009243457A JP5495709B2 (en) | 2009-10-22 | 2009-10-22 | Skin cleanser composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009243457A JP5495709B2 (en) | 2009-10-22 | 2009-10-22 | Skin cleanser composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011088852A JP2011088852A (en) | 2011-05-06 |
JP5495709B2 true JP5495709B2 (en) | 2014-05-21 |
Family
ID=44107446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009243457A Expired - Fee Related JP5495709B2 (en) | 2009-10-22 | 2009-10-22 | Skin cleanser composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5495709B2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5714358B2 (en) * | 2011-02-28 | 2015-05-07 | 株式会社マンダム | Semi-solid cleaning agent |
JP2013100305A (en) * | 2011-12-28 | 2013-05-23 | Neige Corporation:Kk | Gel and semi-solid detergent |
JP7397571B2 (en) * | 2017-12-26 | 2023-12-13 | 花王株式会社 | skin cleansing composition |
FR3089803B1 (en) * | 2018-12-17 | 2020-12-04 | Roquette Freres | Film-forming composition based on legume starch for cosmetic use |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001181680A (en) * | 1999-12-24 | 2001-07-03 | Lion Corp | Detergent composition |
JP2002047123A (en) * | 2000-08-02 | 2002-02-12 | Asahi Kasei Corp | Perfumery |
JP3926723B2 (en) * | 2002-10-25 | 2007-06-06 | 株式会社資生堂 | Frame-kneaded solid skin cleanser |
JP4589050B2 (en) * | 2003-12-22 | 2010-12-01 | 日本精化株式会社 | Diesters and oils, and cosmetics and skin external preparations |
JP2006298868A (en) * | 2005-04-25 | 2006-11-02 | Pola Chem Ind Inc | External preparation for skin, suitable for cleansing cosmetic |
-
2009
- 2009-10-22 JP JP2009243457A patent/JP5495709B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2011088852A (en) | 2011-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5754644B2 (en) | Liquid detergent composition | |
JP2008013513A (en) | Low temperature stable creamy cleanser composition | |
JP5419506B2 (en) | Two-layer cleansing cosmetic | |
JP2007269662A (en) | Creamy skin-cleansing composition | |
JP5522828B2 (en) | Skin cleanser | |
JP2011038004A (en) | Detergent composition | |
JP6237172B2 (en) | Liquid detergent composition | |
JP5897803B2 (en) | Creamy skin cleanser | |
JP5791001B2 (en) | Liquid detergent composition | |
JP5495709B2 (en) | Skin cleanser composition | |
JP4953695B2 (en) | Transparent liquid cleaning material | |
JP2006342293A (en) | Composition for foam detergent and foam detergent | |
JP5919578B1 (en) | Frame kneaded isethionate soap | |
EP1000606B1 (en) | Weak acid skin cleanser containing an alkali salt of N-acyl-amino acid | |
JP2019077642A (en) | Creamy skin cleanser | |
JP3904812B2 (en) | Skin cleanser | |
JP5786180B2 (en) | Skin cleanser | |
JP5522832B2 (en) | Skin cleanser composition | |
JP3889390B2 (en) | Cleaning composition | |
JP2003055690A (en) | Detergent composition | |
JP6320602B1 (en) | Cleaning composition. | |
JP6558202B2 (en) | Cleaning composition | |
JP2005314614A (en) | Detergent composition | |
JP2006188435A (en) | Skin-cleansing agent composition | |
JP7150050B2 (en) | skin cleanser composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120913 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20131010 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131015 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131210 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140304 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140304 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5495709 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |